Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Cash Flows from Operating Activities:
Net Income	$ 408,606	$ 328,060
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	126,656	115,186
Goodwill Impairment	0	36,745
Deferred income taxes	2,190	8,506
Stock-based compensation expense	19,457	23,636
Net (gain) loss on marketable securities	(16,496)	3,241
Net loss (gain) on sales of assets and businesses	2,576	(25,881)
Other	1,244	684
Changes in assets and liabilities, net of effect from purchases and sales of businesses:
Decrease in receivables	430,512	202,742
Decrease (increase) in inventory	55,118	(142,069)
Decrease in prepaid expenses and other current and long-term assets	30,349	4,807
(Decrease) in accounts payable	(83,960)	(195,093)
(Decrease) in accrued compensation and benefits	(20,049)	(54,747)
Increase (decrease) in accrued losses	4,366	(2,119)
(Decrease) in other accrued liabilities	(19,424)	(40,690)
Cash Provided by Operating Activities	941,145	263,008
Cash Flows from Investing Activities:
Capital expenditures	(138,093)	(179,725)
Acquisition of businesses, net of cash acquired	(15,549)	(47,542)
Purchase of marketable securities	(30,591)	(13,173)
Proceeds from sales of marketable securities	22,130	9,596
Proceeds from sales of assets and businesses, net	5,749	53,318
Other	2,485	2,127
Cash (Used for) Investing Activities	(153,869)	(175,399)
Cash Flows from Financing Activities:
Additions to long-term and short-term debt	0	489,881
Reductions of long-term and short-term debt	(516,086)	(354,135)
Cash dividends	(172,601)	(159,841)
Repurchases of common stock	(37,488)	(37,500)
Shares of common stock returned for taxes	(21,949)	(15,252)
Payments of acquisition-related contingent consideration	(1,082)	(3,765)
Other	(1,586)	(2,689)
Cash (Used for) Financing Activities	(750,792)	(83,301)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(3,366)	(12,110)
Net Change in Cash and Cash Equivalents	33,118	(7,802)
Cash and Cash Equivalents at Beginning of Period	215,787	201,672
Cash and Cash Equivalents at End of Period	248,905	193,870
Cash paid during the period for:
Interest	90,770	83,248
Income Taxes, net of refunds	172,008	133,753
Supplemental Disclosures of Noncash Investing Activities:
Capital expenditures accrued within accounts payable at quarter-end	$ 12,621	$ 12,147